Silvia Visentin

Papers

Total Citations

H-Index

About

Silvia Visentin is a pioneering surgeon whose work centers on advancing minimally invasive endocrine surgery, particularly through the adoption of next-generation robotic platforms. Her major contribution lies in systematically evaluating the feasibility and safety of the Da Vinci Single-Port (DV-SP) system for adrenalectomy, a procedure traditionally performed with multi-port robots. In her landmark 2025 systematic review and pooled analysis—already garnering 6 citations—Visentin synthesized early global evidence to demonstrate that DV-SP adrenalectomy is both safe and effective, with favorable perioperative outcomes. This work provides a critical evidence base for surgeons transitioning to single-port robotics, potentially reducing patient trauma and recovery time. Beyond this, Visentin’s research portfolio explores the broader integration of robotic surgery into endocrine practice, aiming to refine techniques that improve patient outcomes. Her contributions are particularly impactful given the rapid evolution of surgical robotics, and her analyses serve as essential guides for clinicians and researchers navigating this transformative field. Visentin’s dedication to evidence-based innovation positions her as a key voice in the future of minimally invasive endocrine surgery.